nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Migraine—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Fatigue—Mitoxantrone—sarcoma	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Discomfort—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Pain—Mitoxantrone—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Constipation—Mitoxantrone—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Hypersensitivity—Thiotepa—sarcoma	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Face oedema—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Hypersensitivity—Dactinomycin—sarcoma	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Gastritis—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Confusional state—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Asthenia—Thiotepa—sarcoma	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Abdominal distension—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—sarcoma	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Feeling abnormal—Mitoxantrone—sarcoma	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Asthma—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Pruritus—Thiotepa—sarcoma	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Eosinophilia—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Abdominal pain—Vincristine—sarcoma	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Body temperature increased—Vincristine—sarcoma	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Urticaria—Mitoxantrone—sarcoma	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Anorexia—Etoposide—sarcoma	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Diarrhoea—Thiotepa—sarcoma	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Abdominal pain—Mitoxantrone—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Body temperature increased—Mitoxantrone—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Bronchitis—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—sarcoma	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Pancytopenia—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Hypotension—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Neutropenia—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Dysuria—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Dizziness—Thiotepa—sarcoma	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Pollakiuria—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vincristine—sarcoma	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Paraesthesia—Etoposide—sarcoma	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Weight increased—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Dyspnoea—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Somnolence—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Hypersensitivity—Mitoxantrone—sarcoma	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Asthenia—Vincristine—sarcoma	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Vomiting—Thiotepa—sarcoma	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—sarcoma	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Rash—Thiotepa—sarcoma	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Dermatitis—Thiotepa—sarcoma	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Headache—Thiotepa—sarcoma	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—sarcoma	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Decreased appetite—Etoposide—sarcoma	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Asthenia—Mitoxantrone—sarcoma	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Fatigue—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Constipation—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Pain—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Diarrhoea—Vincristine—sarcoma	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Nausea—Thiotepa—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Feeling abnormal—Etoposide—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Diarrhoea—Mitoxantrone—sarcoma	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—sarcoma	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Dizziness—Vincristine—sarcoma	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Urticaria—Etoposide—sarcoma	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Body temperature increased—Etoposide—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Abdominal pain—Etoposide—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Vomiting—Vincristine—sarcoma	0.00109	0.00109	CcSEcCtD
Cefpodoxime—Rash—Vincristine—sarcoma	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Dermatitis—Vincristine—sarcoma	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Headache—Vincristine—sarcoma	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Vomiting—Mitoxantrone—sarcoma	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Rash—Mitoxantrone—sarcoma	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Dermatitis—Mitoxantrone—sarcoma	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Headache—Mitoxantrone—sarcoma	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Hypersensitivity—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Nausea—Vincristine—sarcoma	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Cefpodoxime—Asthenia—Etoposide—sarcoma	0.000999	0.000999	CcSEcCtD
Cefpodoxime—Nausea—Mitoxantrone—sarcoma	0.000994	0.000994	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—sarcoma	0.000986	0.000986	CcSEcCtD
Cefpodoxime—Pruritus—Etoposide—sarcoma	0.000985	0.000985	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—sarcoma	0.000961	0.000961	CcSEcCtD
Cefpodoxime—Diarrhoea—Etoposide—sarcoma	0.000952	0.000952	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—sarcoma	0.000948	0.000948	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—sarcoma	0.000942	0.000942	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—sarcoma	0.000936	0.000936	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—sarcoma	0.000929	0.000929	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—sarcoma	0.000925	0.000925	CcSEcCtD
Cefpodoxime—Dizziness—Etoposide—sarcoma	0.000921	0.000921	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—sarcoma	0.000912	0.000912	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—sarcoma	0.000898	0.000898	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—sarcoma	0.000887	0.000887	CcSEcCtD
Cefpodoxime—Vomiting—Etoposide—sarcoma	0.000885	0.000885	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—sarcoma	0.000884	0.000884	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—sarcoma	0.000879	0.000879	CcSEcCtD
Cefpodoxime—Rash—Etoposide—sarcoma	0.000878	0.000878	CcSEcCtD
Cefpodoxime—Dermatitis—Etoposide—sarcoma	0.000877	0.000877	CcSEcCtD
Cefpodoxime—Headache—Etoposide—sarcoma	0.000872	0.000872	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—sarcoma	0.000872	0.000872	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—sarcoma	0.000866	0.000866	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—sarcoma	0.000862	0.000862	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—sarcoma	0.000859	0.000859	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—sarcoma	0.000859	0.000859	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—sarcoma	0.000857	0.000857	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—sarcoma	0.000856	0.000856	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—sarcoma	0.000856	0.000856	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—sarcoma	0.000845	0.000845	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—sarcoma	0.00084	0.00084	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—sarcoma	0.000834	0.000834	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Cefpodoxime—Nausea—Etoposide—sarcoma	0.000827	0.000827	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—sarcoma	0.000821	0.000821	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—sarcoma	0.000818	0.000818	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—sarcoma	0.000814	0.000814	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—sarcoma	0.000814	0.000814	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—sarcoma	0.000813	0.000813	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—sarcoma	0.000811	0.000811	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—sarcoma	0.000798	0.000798	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—sarcoma	0.000796	0.000796	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—sarcoma	0.000795	0.000795	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—sarcoma	0.000793	0.000793	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—sarcoma	0.000792	0.000792	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—sarcoma	0.000787	0.000787	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—sarcoma	0.00078	0.00078	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—sarcoma	0.000778	0.000778	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—sarcoma	0.000772	0.000772	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—sarcoma	0.000768	0.000768	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—sarcoma	0.000754	0.000754	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—sarcoma	0.000753	0.000753	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—sarcoma	0.000753	0.000753	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—sarcoma	0.000751	0.000751	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—sarcoma	0.000744	0.000744	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—sarcoma	0.000744	0.000744	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—sarcoma	0.000737	0.000737	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—sarcoma	0.000729	0.000729	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—sarcoma	0.000722	0.000722	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000711	0.000711	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—sarcoma	0.00071	0.00071	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—sarcoma	0.000707	0.000707	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—sarcoma	0.000706	0.000706	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—sarcoma	0.000701	0.000701	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—sarcoma	0.000698	0.000698	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—sarcoma	0.000696	0.000696	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—sarcoma	0.000688	0.000688	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—sarcoma	0.000687	0.000687	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—sarcoma	0.000678	0.000678	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—sarcoma	0.000675	0.000675	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—sarcoma	0.000674	0.000674	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—sarcoma	0.000667	0.000667	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—sarcoma	0.000667	0.000667	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000658	0.000658	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—sarcoma	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—sarcoma	0.000648	0.000648	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—sarcoma	0.000644	0.000644	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—sarcoma	0.000643	0.000643	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—sarcoma	0.000638	0.000638	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—sarcoma	0.000636	0.000636	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—sarcoma	0.000628	0.000628	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000623	0.000623	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—sarcoma	0.000622	0.000622	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—sarcoma	0.00062	0.00062	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—sarcoma	0.000617	0.000617	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—sarcoma	0.000617	0.000617	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—sarcoma	0.000617	0.000617	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—sarcoma	0.000617	0.000617	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—sarcoma	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—sarcoma	0.00059	0.00059	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—sarcoma	0.000575	0.000575	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—sarcoma	0.000574	0.000574	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—sarcoma	0.000571	0.000571	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—sarcoma	0.000571	0.000571	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—sarcoma	0.00056	0.00056	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—sarcoma	0.000552	0.000552	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—sarcoma	0.000534	0.000534	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—sarcoma	0.000532	0.000532	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—sarcoma	0.000518	0.000518	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—sarcoma	0.000516	0.000516	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—sarcoma	0.000511	0.000511	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—sarcoma	0.000496	0.000496	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—sarcoma	0.000494	0.000494	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—sarcoma	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—sarcoma	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—sarcoma	0.000489	0.000489	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—sarcoma	0.000477	0.000477	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—sarcoma	0.000464	0.000464	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—sarcoma	0.000459	0.000459	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—sarcoma	0.000455	0.000455	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—sarcoma	0.000455	0.000455	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—sarcoma	0.000452	0.000452	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—sarcoma	0.000429	0.000429	CcSEcCtD
